Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 4:持股变动声明-董事 Behbahani Ali
Black Diamond Therapeutics | 4:持股变动声明-董事 Raman Prakash
Black Diamond Therapeutics | 4:持股变动声明-董事 Campbell Shannon
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 144:拟议出售证券
Black Diamond Therapeutics | 4:持股变动声明-董事 Behbahani Ali
Black Diamond Therapeutics | 4:持股变动声明-董事 Kulkarni Samarth
Black Diamond Therapeutics | 4:持股变动声明-董事 Menzel Garry E
Black Diamond Therapeutics | 4:持股变动声明-董事 Raman Prakash
Black Diamond Therapeutics | 4:持股变动声明-董事 Campbell Shannon
Black Diamond Therapeutics | 4:持股变动声明-董事 Dhingra Kapil
Black Diamond Therapeutics | 8-K:重大事件
Black Diamond Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Ali Behbahani(8.1%),New Enterprise Associates 16, L.P.(7.9%)等
暂无数据